Sqz Biotechnologies Stock Market Value

At this point, SQZ Biotechnologies is out of control. SQZ Biotechnologies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0221, which indicates the firm had a 0.0221 % return per unit of risk over the last 3 months. We have found eighteen technical indicators for SQZ Biotechnologies, which you can use to evaluate the volatility of the company. Please validate SQZ Biotechnologies' Coefficient Of Variation of 33993.6, variance of 22.79, and Risk Adjusted Performance of 0.0106 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. SQZ Biotechnologies has a performance score of 1 on a scale of 0 to 100. The entity has a beta of -0.59, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning SQZ Biotechnologies are expected to decrease at a much lower rate. During the bear market, SQZ Biotechnologies is likely to outperform the market. SQZ Biotechnologies presently has a risk of 4.81%. Please validate SQZ Biotechnologies market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis , to decide if SQZ Biotechnologies will be following its existing price patterns.